Donna Catamero, ANP-BC, OCN, CCRC, discusses the importance of quickly identifying and managing adverse effects from CAR T-cell therapy in patients with multiple myeloma.
Adverse Event Management
Advertisement
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Intensified First-Line Therapy for dMMR/MSI-H mCRC: Nursing Implications of the COMMIT Trial
2
15,000 NYC Nurses Strike Highlights Impact on Oncology Care
3
JSKN003 Given FDA Breakthrough Therapy Status in HER2+ PROC
4
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer?
5